FDA’s Bumpus Will Be Principal Deputy Commissioner; Cosmetics Industry Reacts With Congratulations, Questions.

Wade Ackerman and Jessica O’Connell’s commentary was included in an article by HBW Insight covering the cosmetics industry’s reaction to Namandjé Bumpus replacing Janet Woodcock as principal deputy commissioner at the Food and Drug Administration (FDA). Wade and Jessica provided their analyses on what Bumpus’ appointment will mean for the agency and the industry.

Wade acknowledged that Woodcock leaves large shoes to fill, but said Bumpus “is a great choice" to fill them. "Dr. Bumpus has been a strong chief scientist at FDA, leading agency efforts on a number of fronts, including implementation of the recent legislation overhauling FDA's oversight of cosmetics," he said.

Jessica added that Bumpus has done an excellent job of starting and leading the implementation of the Modernization of Cosmetics Regulation Act (MoCRA) and expressed confidence about the path forward. She commented, “I don't have any immediate concerns about this impacting FDA's speed of implementing MoCRA – we've seen continued efforts from FDA on MoCRA implementation since the legislation passed and I think it's clear that the implementation process is in progress and moving forward."